Work

Breaking barriers: Aptamers in ocular disease treatment

Year: 2024

Type: article

Abstract: Ocular diseases, including visual impairment and blindness, are projected to affect over 280 million people by 2040, imposing substantial economic burdens and drastically reducing the quality of life for those affected.1 Due to the existence of a blood-retinal barrier, current treatments often involve invasive procedures, such as intravitreal injections, which lead to serious side effects and poor patient compliance. There is a pressing need for more efficient and patient-friendly treatment options.

Source: Molecular Therapy — Nucleic Acids

DOI: 10.1016/j.omtn.2024.102399

Authors: Tao Wang, Rakesh Naduvile Veedu

Institutions: The Kids Research Institute Australia, The University of Western Australia, Murdoch University

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,900